✦ LIBER ✦

1166 PUBLICATION Effect of second-line chemotherapy on survival of patients with advanced non-small cell lung cancer pre-treated with docetaxel-based front-line chemotherapy: a retrospective survival analysis

Book ID: 122417516
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 124 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(05)81460-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes of small-cell lung cancer patie

Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: A multi-institutional retrospective analysis

✍ Garassino, Marina Chiara; Torri, Valter; Michetti, Giovanni; Lo Dico, Monica; La 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 476 KB

Second-Line Chemotherapy with a Modified

Second-Line Chemotherapy with a Modified Schedule of Docetaxel in Elderly Patients with Advanced-Stage Non-Small-Cell Lung Cancer

✍ Carmelo Tibaldi; Ilaria Bernardini; Antonio Chella; Francesa Russo; Enrico Vasil 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 134 KB

A Retrospective Analysis of Second-Line

A Retrospective Analysis of Second-Line Chemotherapy or Best Supportive Care in Patients with Advanced-Stage Non–Small-Cell Lung Cancer

✍ Dora Hatzidaki; Sofia Agelaki; Dimitris Mavroudis; Ioannis Vlachonikolis; Athana 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 160 KB

148PD OUTCOMES OF SMALL CELL LUNG CANCER

148PD OUTCOMES OF SMALL CELL LUNG CANCER (SCLC) PATIENTS TREATED WITH SECOND-LINE CHEMOTHERAPY (SL): A RETROSPECTIVE ANALYSIS OF 166 PATIENTS

✍ Garassino, M.C.; Califano, R.; Michetti, G.; Borgonovo, K.; Dico, M. Lo; Fatigon 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

DNA Repair Capacity in Peripheral Lympho

DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non-Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy

✍ Wang, L.-E.; Yin, M.; Dong, Q.; Stewart, D. J.; Merriman, K. W.; Amos, C. I.; Sp 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 150 KB

A dose-escalation study of irinotecan (C

A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy

✍ Kakolyris, S; Souglakos, J; Agelaki, S; Kourousis, Ch; Mavroudis, D; Sarra, E; M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 66 KB